These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39415072)

  • 41. Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients.
    Zhao DT; Yan HP; Han Y; Zhang WM; Zhao Y; Liao HY
    Front Endocrinol (Lausanne); 2023; 14():1142177. PubMed ID: 38027142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    Shaheen AA; Kaplan GG; Almishri W; Vallerand I; Frolkis AD; Patten S; Swain MG
    PLoS One; 2018; 13(4):e0194839. PubMed ID: 29617396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Galoosian A; Hanlon C; Tana M; Cheung R; Wong RJ
    Dig Dis Sci; 2020 Feb; 65(2):406-415. PubMed ID: 31489564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
    Zhang Y; Fan X; Song B; Liu Y; Chen Y; Zheng T; Guo Y; Duan T; Huang Z; Yang L
    Eur Radiol; 2024 Feb; 34(2):1268-1279. PubMed ID: 37581659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive Value of International Classification of Diseases Codes for Idiopathic Intracranial Hypertension in a University Health System.
    Khushzad F; Kumar R; Muminovic I; Moss HE
    J Neuroophthalmol; 2021 Dec; 41(4):e679-e683. PubMed ID: 34788247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients.
    Namisaki T; Moriya K; Kitade M; Kawaratani H; Takeda K; Okura Y; Takaya H; Nishimura N; Seki K; Kaji K; Sato S; Sawada Y; Yamao J; Mitoro A; Uejima M; Mashitani T; Shimozato N; Nakanishi K; Furukawa M; Saikawa S; Kubo T; Yoshiji H
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):23-30. PubMed ID: 27755231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
    Hirschfield GM; Beuers U; Kupcinskas L; Ott P; Bergquist A; Färkkilä M; Manns MP; Parés A; Spengler U; Stiess M; Greinwald R; Pröls M; Wendum D; Drebber U; Poupon R
    J Hepatol; 2021 Feb; 74(2):321-329. PubMed ID: 32950590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.
    Lo Re V; Haynes K; Goldberg D; Forde KA; Carbonari DM; Leidl KB; Hennessy S; Reddy KR; Pawloski PA; Daniel GW; Cheetham TC; Iyer A; Coughlin KO; Toh S; Boudreau DM; Selvam N; Cooper WO; Selvan MS; VanWormer JJ; Avigan MI; Houstoun M; Zornberg GL; Racoosin JA; Shoaibi A
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):861-72. PubMed ID: 23801638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
    Carbone M; Nardi A; Flack S; Carpino G; Varvaropoulou N; Gavrila C; Spicer A; Badrock J; Bernuzzi F; Cardinale V; Ainsworth HF; Heneghan MA; Thorburn D; Bathgate A; Jones R; Neuberger JM; Battezzati PM; Zuin M; Taylor-Robinson S; Donato MF; Kirby J; Mitchell-Thain R; Floreani A; Sampaziotis F; Muratori L; Alvaro D; Marzioni M; Miele L; Marra F; Giannini E; Gaudio E; Ronca V; Bonato G; Cristoferi L; Malinverno F; Gerussi A; Stocken DD; Cordell HJ; Hirschfield GM; Alexander GJ; Sandford RN; Jones DE; Invernizzi P; Mells GF;
    Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):626-634. PubMed ID: 30017646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.
    Lu M; Zhou Y; Haller IV; Romanelli RJ; VanWormer JJ; Rodriguez CV; Anderson H; Boscarino JA; Schmidt MA; Daida YG; Sahota A; Vincent J; Bowlus CL; Lindor K; Zhang T; Trudeau S; Li J; Rupp LB; Gordon SC;
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1342-1350.e1. PubMed ID: 29277621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
    Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L
    Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel.
    Walsh KE; Cutrona SL; Foy S; Baker MA; Forrow S; Shoaibi A; Pawloski PA; Conroy M; Fine AM; Nigrovic LE; Selvam N; Selvan MS; Cooper WO; Andrade S
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1205-13. PubMed ID: 24038742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
    Bowlus CL; Kenney JT; Rice G; Navarro R
    J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affairs Health Care System.
    Hou JK; Tan M; Stidham RW; Colozzi J; Adams D; El-Serag H; Waljee AK
    Dig Dis Sci; 2014 Oct; 59(10):2406-10. PubMed ID: 24817338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of the Accuracy of Using ICD-9 Diagnosis Codes to Identify Pneumonia Etiology in Patients Hospitalized With Pneumonia.
    Higgins TL; Deshpande A; Zilberberg MD; Lindenauer PK; Imrey PB; Yu PC; Haessler SD; Richter SS; Rothberg MB
    JAMA Netw Open; 2020 Jul; 3(7):e207750. PubMed ID: 32697323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
    Graham RP; Smyrk TC; Zhang L
    Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
    Khalifa A; Obeid JS; Gregoski MJ; Rockey DC
    Dig Dis Sci; 2023 Jun; 68(6):2360-2369. PubMed ID: 36899112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Hegade VS; Khanna A; Walker LJ; Wong LL; Dyson JK; Jones DEJ
    Dig Dis Sci; 2016 Oct; 61(10):3037-3044. PubMed ID: 27435324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.